Biotech Values

[pollyvonwog]

Should Teva announce a meaningful setback here, we would expect MNTA shares to move above $20. [This is silly, IMO; why does Wedbush think Teva will be honest with investors about setbacks to the Lovenox ANDA?]

Unbelievably, Wedbush was more or less on to something here.